Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04432857 |
| Title | AN0025 and Pembrolizumab Combination in Advanced Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Adlai Nortye Biopharma Co., Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Washington University School of Medicine - Siteman Cancer Center | Saint Louis | Missouri | 63110 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| University of Utah School of Medicine Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | United States | Details | |
| University of Virginia | Richmond | Virginia | 22908 | United States | Details | |
| Centre Léon Bérard | Lyon | France | Details | |||
| Gustave Roussy | Paris | 94805 | France | Details |